Concord Medical Services
4 hedge funds and large institutions have $77.2K invested in Concord Medical Services in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
196% more capital invested
Capital invested by funds: $26K → $77.2K (+$51.1K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$9.65K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.45K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.07K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$14 |
CCM Hedge Fund Activity: Q2 2024 in Review
4 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2024, worth a combined $77.2K — up 196% from $26K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CCM positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was RhumbLine Advisers, adding an estimated $9.65K. The largest seller was Renaissance Technologies, cutting an estimated $1.07K.
- 4 institutional investors held Concord Medical Services (CCM) as of Q2 2024, up from 3 in Q1 2024.
- Funds reported $77.2K of Concord Medical Services stock for Q2 2024, up 196% quarter-over-quarter.
- 2 funds opened new Concord Medical Services positions in Q2 2024 and 1 closed out, a net change of +1 holder.
- The largest Concord Medical Services buyer in Q2 2024 was RhumbLine Advisers, an estimated $9.65K added.
- The largest Concord Medical Services seller in Q2 2024 was Renaissance Technologies, an estimated $1.07K sold.
Based on aggregated 13F filings for Q2 2024.